Recombinate is a Kit in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is .
Product ID | 0944-2832_6eb61ecd-d264-4163-ba11-26d4816062f3 |
NDC | 0944-2832 |
Product Type | Human Prescription Drug |
Proprietary Name | Recombinate |
Generic Name | Antihemophilic Factor Recombinant |
Dosage Form | Kit |
Marketing Start Date | 2010-02-08 |
Marketing Category | BLA / BLA |
Application Number | BLA103375 |
Labeler Name | Baxter Healthcare Corporation |
Active Ingredient Strength | 0 |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2010-02-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103375 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-02-08 |
Marketing End Date | 2013-02-03 |
Marketing Category | BLA |
Application Number | BLA103375 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-02-08 |
Marketing End Date | 2010-08-14 |
SPL SET ID: | 2a569ec5-08d7-44ab-b649-384a496e173c |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0944-2831 | Recombinate | Antihemophilic Factor Recombinant |
0944-2832 | Recombinate | Antihemophilic Factor Recombinant |
0944-2833 | Recombinate | Antihemophilic Factor Recombinant |
0944-2841 | RECOMBINATE | antihemophilic factor recombinant |
0944-2842 | RECOMBINATE | antihemophilic factor recombinant |
0944-2843 | RECOMBINATE | antihemophilic factor recombinant |
0944-2844 | RECOMBINATE | antihemophilic factor recombinant |
0944-2845 | RECOMBINATE | antihemophilic factor recombinant |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RECOMBINATE 97043921 not registered Live/Pending |
Baxalta Incorporated 2021-09-24 |
RECOMBINATE 74229857 not registered Dead/Abandoned |
Baxter International Inc. 1991-12-12 |
RECOMBINATE 73796939 not registered Dead/Abandoned |
BAXTER INTERNATIONAL INC. 1989-05-01 |